• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, November 18, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Blocking IL-6 Trans-Signaling Protects the Heart in Mouse Sepsis Study

by
October 30, 2026
in Health
Reading Time: 3 mins read
0
Blocking IL-6 Trans-Signaling Protects the Heart in Mouse Sepsis Study

Blocking IL-6 Trans-Signaling Protects the Heart in Mouse Sepsis Study

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Sepsis can leave the heart struggling to pump, a complication known as sepsis-induced myocardial dysfunction, and it carries a high mortality risk. A new study published in BMC Immunology reports that a selective inhibitor of the IL-6 trans-signaling pathway, a fusion protein called sgp130Fc, improved cardiac function and survival in a mouse model of this condition, and identifies suppression of the JAK/STAT3 signaling pathway as the likely mechanism behind the protection.

The research team, led by Xuefang Liu and Zhenjie Hu, began with human evidence. Analyzing serum samples from septic patients with and without cardiac dysfunction, they found that concentrations of IL-6, its soluble receptor sIL-6R, and cardiac injury biomarkers including troponin I (cTnI), CK-MB, and NT-proBNP were significantly elevated in sepsis, and highest in patients whose hearts were affected. Markers of fibrosis and endothelial dysfunction also rose, while levels of sgp130, the natural decoy receptor that normally restrains IL-6 trans-signaling, were notably reduced. This pattern suggested that the pathway is hyperactivated precisely when the myocardium is under attack.

To test whether blocking the pathway helps, the researchers used a mouse model of sepsis-induced myocardial dysfunction created by cecal ligation and puncture, a standard surgical technique that induces polymicrobial sepsis. Treated animals received sgp130Fc, a selective inhibitor of IL-6 trans-signaling. According to the study, the intervention significantly enhanced survival rates and cardiac function, assessed by echocardiography through two standard pumping measures: left ventricular ejection fraction (LVEF) and left ventricular fractional shortening (LVFS).

The structural evidence supported the functional gains. Histopathological analysis, including hematoxylin and eosin staining, Masson’s trichrome staining for collagen deposition, and TUNEL assays for cell death, showed that sgp130Fc suppressed inflammatory cytokine production and circulating injury biomarkers, decreased cardiomyocyte apoptosis, and mitigated myocardial fibrosis. Transmission electron microscopy added a subcellular dimension: the treated mice preserved the integrity of mitochondria and other myocardial ultrastructure that sepsis typically disrupts.

Because the heart is built from more than one cell type, the team extended the work in vitro using LPS-stimulated cardiomyocytes, cardiac fibroblasts, and cardiac microvascular endothelial cells, the three major cell populations implicated in septic myocardial injury. In all three, sgp130Fc restored cell viability, attenuated inflammatory and fibrotic responses, and improved functional properties including proliferation, migration, and the regulation of apoptosis. The authors describe this as comprehensive, multi-cellular cardioprotection rather than an effect confined to contracting muscle cells.

The mechanistic core of the study lies in rescue experiments with a JAK agonist. When the agonist was administered alongside sgp130Fc in both the mouse model and the cell cultures, it effectively counteracted the protective effects of the inhibitor. Conversely, sgp130Fc treatment markedly inhibited activation of the JAK/STAT3 pathway, and the agonist restored that activity. This bidirectional experiment supports the conclusion that the benefits of blocking IL-6 trans-signaling run primarily through multi-cellular inhibition of JAK/STAT3 signaling.

The findings fit a broader biological logic. The observation that endogenous sgp130 falls in septic patients with cardiac dysfunction, while ligand and soluble receptor rise, frames the disease state as one in which the pathway’s natural brake fails.

Important limitations temper the excitement. The therapeutic results come from a mouse model and from cells exposed to a bacterial endotoxin in a dish, not from human trials; the human data are observational serum measurements showing association, not evidence that blocking the pathway improves outcomes in patients. The article is also being shared early as a peer-reviewed, accepted manuscript that remains subject to further editorial revision before the final version of record.

Even so, the study offers a coherent preclinical case: IL-6 trans-signaling is hyperactivated in sepsis-induced myocardial dysfunction, contributes to myocardial injury through JAK/STAT3-driven inflammation, apoptosis, fibrosis, and mitochondrial damage, and can be targeted with a pathway-selective inhibitor that protected survival, pumping function, and tissue architecture in mice. The authors conclude that targeting IL-6 trans-signaling with sgp130Fc represents a promising therapeutic strategy for SIMD, one that now awaits validation in human studies.

Subject of Research: Preclinical evaluation of IL-6 trans-signaling inhibition with sgp130Fc in sepsis-induced myocardial dysfunction

Article Title: Study on the effect of inhibiting IL-6 trans-signaling pathway on cardiac function in sepsis-induced heart dysfunction mice and its mechanism

Article References: Liu, X., Yu, N., Tian, W., Chen, Y., Zhang, X., Yang, K., Liu, Y., & Hu, Z. (2026). Study on the effect of inhibiting IL-6 trans-signaling pathway on cardiac function in sepsis-induced heart dysfunction mice and its mechanism. BMC Immunology. https://doi.org/10.1186/s12865-026-00894-w

Image Credits: AI Generated

DOI: 10.1186/s12865-026-00894-w

Keywords: sepsis, sepsis-induced myocardial dysfunction, IL-6 trans-signaling, sgp130Fc, JAK/STAT3 pathway, cardiac function, cardiomyocyte apoptosis, myocardial fibrosis, echocardiography, preclinical study, BMC Immunology, effect

News Source: Ophelia Keating. (October 30, 2026). Blocking IL-6 Trans-Signaling Protects the Heart in Mouse Sepsis Study. Scienmag.

Tags: BMC Immunologycardiac functioncardiomyocyte apoptosisechocardiographyeffectIL-6 trans-signalingJAK/STAT3 pathwaymyocardial fibrosispreclinical studysepsissepsis-induced myocardial dysfunctionsgp130Fc
Share12Tweet7Share2ShareShareShare1

Related Posts

App-Guided Ear Acupressure Cuts Chronic Musculoskeletal Pain in Pilot Trial

App-Guided Ear Acupressure Cuts Chronic Musculoskeletal Pain in Pilot Trial

November 18, 2026
Decitabine Restores Osimertinib Sensitivity in Resistant Lung Cancer via Autophagy Pathway

Decitabine Restores Osimertinib Sensitivity in Resistant Lung Cancer via Autophagy Pathway

November 18, 2026

Cumulative Vascular Compromise Drives Rare Maxillary Necrosis After Le Fort Osteotomy

November 18, 2026

Off-Hour Births in African Hospitals Linked to Increased Early Neonatal Mortality Risk

November 18, 2026

POPULAR NEWS

  • Spain NTD Drug Study Reveals Severe Territorial Gaps Across Autonomous Communities

    Spain NTD Drug Study Reveals Severe Territorial Gaps Across Autonomous Communities

    29 shares
    Share 12 Tweet 7
  • Guinea Health Study Reveals Severe Workforce Unemployment Despite Rising Professional Training

    29 shares
    Share 12 Tweet 7
  • Rootstock Signaling Networks Dynamically Reprogram Fruit Quality Across Horticultural Crops

    29 shares
    Share 12 Tweet 7
  • Review Uncovers How Group 2 Innate Lymphoid Cells Bridge Neuroimmune Communication

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Structural Modifications Shield High-Temperature Carbon Foams Against Rapid Oxidation Failure

Spinal Cord Injury Index Tracks Intraoperative Trauma During Spinal Cord Tumor Resection

App-Guided Ear Acupressure Cuts Chronic Musculoskeletal Pain in Pilot Trial

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.